FMP
NASDAQ
36.01 USD
0 (0%)
Dr. Hugh Young Rienhoff Jr., M.D.
Healthcare
Biotechnology
https://www.imagobio.com
NASDAQ
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
0001623715
US45250K1079
45250K107
329 Oyster Point Boulevard
415 529 5055
US
41
Jul 16, 2021
0001623715
NASDAQ
Biotechnology
Healthcare
45250K107
US45250K1079
US
36.01
0
762.78k
0
-
11.56-36.09
0
-
-
-
-
0
-
https://www.imagobio.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.